Dr. Papadopoulos was on the faculty of the Department of Cell Biology at New York University School of Medicine. He maintains his affiliation with NYU as an adjunct associate professor of cell biology.

  Stelios Papadopoulos, Ph.D., has served on our Board of Directors since 2008 and was appointed as Chairman in June 2014. He is a member of our Audit Committee, Finance Committee and Science and Technology Committee. Dr. Papadopoulos is the Chairman of the Board of Directors of Exelixis, Inc., a drug discovery and development company that he co-founded in 1994. He is also the Chairman of Regulus Therapeutics, Inc., and a member of the Board of Directors of BG Medicine, Inc., both life sciences companies. He co-founded Anadys Pharmaceuticals, Inc., in 2000 and was a member of its Board of Directors until its acquisition by Hoffman-La Roche in 2011, serving as the Chairman of the board during 2011. In the not-for-profit sector, Dr. Papadopoulos is a co-founder and Chairman of Fondation Santé, a member of the Board of Visitors of Duke Medicine and a member of the Global Advisory Board of the Duke Institute for Health Innovation.